CatalystFDA/Bio

BRISTOL GAINS ACCELERATED APPROVAL OF IBERDOMIDE FOR MULTIPLE MYELOMA - SEEKINGALPHA

FDA accelerated approval for multiple myeloma is a major regulatory catalyst.

What changed

Why it matters

FDA accelerated approval for multiple myeloma is a major regulatory catalyst.

Sources